325 related articles for article (PubMed ID: 26109645)
1. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age.
Raynor J; Karns R; Almanan M; Li KP; Divanovic S; Chougnet CA; Hildeman DA
J Immunol; 2015 Aug; 195(3):944-52. PubMed ID: 26109645
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.
Herman AE; Freeman GJ; Mathis D; Benoist C
J Exp Med; 2004 Jun; 199(11):1479-89. PubMed ID: 15184501
[TBL] [Abstract][Full Text] [Related]
4. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
5. CD28 controls differentiation of regulatory T cells from naive CD4 T cells.
Guo F; Iclozan C; Suh WK; Anasetti C; Yu XZ
J Immunol; 2008 Aug; 181(4):2285-91. PubMed ID: 18684917
[TBL] [Abstract][Full Text] [Related]
6. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
[TBL] [Abstract][Full Text] [Related]
7. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
[TBL] [Abstract][Full Text] [Related]
8. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
9. A major role for Bim in regulatory T cell homeostasis.
Chougnet CA; Tripathi P; Lages CS; Raynor J; Sholl A; Fink P; Plas DR; Hildeman DA
J Immunol; 2011 Jan; 186(1):156-63. PubMed ID: 21098226
[TBL] [Abstract][Full Text] [Related]
10. mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3
Sun IH; Oh MH; Zhao L; Patel CH; Arwood ML; Xu W; Tam AJ; Blosser RL; Wen J; Powell JD
J Immunol; 2018 Jul; 201(2):481-492. PubMed ID: 29884702
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.
Sakthivel P; Grunewald J; Eklund A; Bruder D; Wahlström J
Clin Exp Immunol; 2016 Feb; 183(2):294-306. PubMed ID: 26415669
[TBL] [Abstract][Full Text] [Related]
12. Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.
Lutz C; Mozaffari M; Tosevski V; Caj M; Cippà P; McRae BL; Graff CL; Rogler G; Fried M; Hausmann M
Clin Exp Immunol; 2015 Aug; 181(2):343-56. PubMed ID: 25845418
[TBL] [Abstract][Full Text] [Related]
13. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
Han Y; Guo Q; Zhang M; Chen Z; Cao X
J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
15. Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity.
Vicente R; Quentin J; Mausset-Bonnefont AL; Chuchana P; Martire D; Cren M; Jorgensen C; Louis-Plence P
J Immunol; 2016 Jan; 196(1):298-309. PubMed ID: 26590312
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
[TBL] [Abstract][Full Text] [Related]
17. Developmental Progression and Interrelationship of Central and Effector Regulatory T Cell Subsets.
Toomer KH; Yuan X; Yang J; Dee MJ; Yu A; Malek TR
J Immunol; 2016 May; 196(9):3665-76. PubMed ID: 27009492
[TBL] [Abstract][Full Text] [Related]
18. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
20. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
